LL-37 is a peptide studied in laboratory research for its potential role in immune research. It is a naturally occurring antimicrobial peptide that is studied in research on immune processes and related physiological pathways.
What Are the Key LL-37 Research Specifications?
| Specification | Research record |
|---|---|
| Compound | LL-37 |
| Category | misc |
| Listed purity | >99% |
| Molecular weight | ~4.5 kDa |
| Intended use | Laboratory research only |
What Is the Chemical Structure of LL-37?
LL-37 is a peptide with a molecular weight of approximately 4.5 kDa. It is a peptide with a sequence of 37 amino acids.
How Should LL-37 Analytical Quality Be Verified?
For LL-37, HPLC area purity should be read together with an orthogonal identity result. The LL-37 lot record should specify the molecular form, chromatographic method and intact-mass or spectroscopic confirmation. HPLC area alone does not establish LL-37 content, counterion, water, residual solvent or endotoxin; those variables can alter molar calculations and biological assays.
What Does Current Research Establish About LL-37?
LL-37 is the 37-residue cationic amphipathic human cathelicidin peptide. Salt, serum, plastics and endotoxin strongly influence antimicrobial and immunological assays, so minimal inhibitory concentration alone is insufficient characterization.
A citable LL-37 evidence unit identifies the model, concentration, comparator, target-proximal readout and analytical identity. LL-37 results from animals, isolated cells and receptor assays answer different questions; they should not be collapsed into a medical claim or a single undifferentiated evidence tier.
What Should Researchers Report When Studying LL-37?
Define the complete LL-37 molecular form: sequence or structure, terminal modifications, counterion, formula mass and lot-specific content. Use a concentration-response series, time-matched vehicle and a target-dependent control rather than relying on a single descriptive phenotype. Verify LL-37 recovery at the working concentration, prepare single-use aliquots and avoid repeated freeze-thaw cycles. For cell assays, report endotoxin and serum conditions. HPLC area purity should be paired with intact-mass or spectroscopic identity and an assay appropriate to the proposed mechanism.
Where Can Researchers Verify LL-37 Sources?
Use PubMed’s indexed LL-37 literature to locate primary studies and PubChem’s LL-37 records to cross-check structures and identifiers. Match every citation to the exact sequence, ester, salt or formulation documented for the lot; a shared trade name does not prove chemical equivalence.
How Can LL-37 Results Be Interpreted Without Overclaiming?
The strongest LL-37 evidence connects identity to mechanism to phenotype in that order. For LL-37, chemical identity, target engagement and downstream phenotype are separate layers. A change in migration, viability or gene expression does not by itself prove the proposed molecular target. A useful study includes an orthogonal analytical identity check, a target-dependent perturbation and a second assay that measures the same biology by a different method. This design makes a positive result easier to reproduce and a negative result easier to interpret.
For citation-ready LL-37 reporting, provide raw concentration units, biological replicate counts, prespecified exclusions and the exact time point. Separate exploratory endpoints from confirmatory ones. If exposure was not measured, describe potency as nominal rather than intracellular or free concentration. Limit the conclusion to the model used; avoid converting a pathway observation into a claim about clinical benefit.
Is LL-37 for Research Use Only?
LL-37 is supplied for controlled laboratory research only. It is not intended for human or veterinary use. Browse Miscellaneous Research Peptides
What Are Common Questions About LL-37?
What is LL-37?
LL-37 is a peptide studied in laboratory research for its potential role in immune research. It is a naturally occurring antimicrobial peptide that is studied in research on immune processes and related physiological pathways.
How should researchers verify LL-37?
Confirm the exact molecular form on the lot certificate and pair chromatographic purity with an orthogonal identity method such as mass spectrometry or NMR. Use the molecular weight, counterion and content stated for that verified form when calculating molarity.
Is LL-37 intended for human use?
LL-37 is listed for controlled laboratory research only. It is not intended for human or veterinary use.